434 related articles for article (PubMed ID: 23349811)
1. p68/DdX5 supports β-catenin & RNAP II during androgen receptor mediated transcription in prostate cancer.
Clark EL; Hadjimichael C; Temperley R; Barnard A; Fuller-Pace FV; Robson CN
PLoS One; 2013; 8(1):e54150. PubMed ID: 23349811
[TBL] [Abstract][Full Text] [Related]
2. The RNA helicase p68 is a novel androgen receptor coactivator involved in splicing and is overexpressed in prostate cancer.
Clark EL; Coulson A; Dalgliesh C; Rajan P; Nicol SM; Fleming S; Heer R; Gaughan L; Leung HY; Elliott DJ; Fuller-Pace FV; Robson CN
Cancer Res; 2008 Oct; 68(19):7938-46. PubMed ID: 18829551
[TBL] [Abstract][Full Text] [Related]
3. DEAD-box protein p68 is regulated by β-catenin/transcription factor 4 to maintain a positive feedback loop in control of breast cancer progression.
Guturi KK; Sarkar M; Bhowmik A; Das N; Ghosh MK
Breast Cancer Res; 2014 Dec; 16(6):496. PubMed ID: 25499975
[TBL] [Abstract][Full Text] [Related]
4. FOXM1 promotes the progression of prostate cancer by regulating PSA gene transcription.
Liu Y; Liu Y; Yuan B; Yin L; Peng Y; Yu X; Zhou W; Gong Z; Liu J; He L; Li X
Oncotarget; 2017 Mar; 8(10):17027-17037. PubMed ID: 28199985
[TBL] [Abstract][Full Text] [Related]
5. The DEAD-box RNA helicase DDX5 (p68) and β-catenin: The crucial regulators of FOXM1 gene expression in arbitrating colorectal cancer.
Tabassum S; Basu M; Ghosh MK
Biochim Biophys Acta Gene Regul Mech; 2023 Jun; 1866(2):194933. PubMed ID: 36997114
[TBL] [Abstract][Full Text] [Related]
6. Coupling transcription to RNA processing via the p68 DEAD box RNA helicase androgen receptor co-activator in prostate cancer.
Clark EL; Fuller-Pace FV; Elliott DJ; Robson CN
Biochem Soc Trans; 2008 Jun; 36(Pt 3):546-7. PubMed ID: 18482004
[TBL] [Abstract][Full Text] [Related]
7. The androgen receptor can signal through Wnt/beta-Catenin in prostate cancer cells as an adaptation mechanism to castration levels of androgens.
Schweizer L; Rizzo CA; Spires TE; Platero JS; Wu Q; Lin TA; Gottardis MM; Attar RM
BMC Cell Biol; 2008 Jan; 9():4. PubMed ID: 18218096
[TBL] [Abstract][Full Text] [Related]
8. RNA helicase p68 deploys β-catenin in regulating RelA/p65 gene expression: implications in colon cancer.
Khare V; Tabassum S; Chatterjee U; Chatterjee S; Ghosh MK
J Exp Clin Cancer Res; 2019 Jul; 38(1):330. PubMed ID: 31351496
[TBL] [Abstract][Full Text] [Related]
9. Lupeol, a novel androgen receptor inhibitor: implications in prostate cancer therapy.
Siddique HR; Mishra SK; Karnes RJ; Saleem M
Clin Cancer Res; 2011 Aug; 17(16):5379-91. PubMed ID: 21712449
[TBL] [Abstract][Full Text] [Related]
10. Functional localization and competition between the androgen receptor and T-cell factor for nuclear beta-catenin: a means for inhibition of the Tcf signaling axis.
Mulholland DJ; Read JT; Rennie PS; Cox ME; Nelson CC
Oncogene; 2003 Aug; 22(36):5602-13. PubMed ID: 12944908
[TBL] [Abstract][Full Text] [Related]
11. LINE-1 ORF-1p functions as a novel androgen receptor co-activator and promotes the growth of human prostatic carcinoma cells.
Lu Y; Feng F; Yang Y; Gao X; Cui J; Zhang C; Zhang F; Xu Z; Qv J; Wang C; Zeng Z; Zhu Y; Yang Y
Cell Signal; 2013 Feb; 25(2):479-89. PubMed ID: 23153584
[TBL] [Abstract][Full Text] [Related]
12. Wnt/β-catenin signaling and p68 conjointly regulate CHIP in colorectal carcinoma.
Kal S; Chakraborty S; Karmakar S; Ghosh MK
Biochim Biophys Acta Mol Cell Res; 2022 Mar; 1869(3):119185. PubMed ID: 34890713
[TBL] [Abstract][Full Text] [Related]
13. Prosaposin upregulates AR and PSA expression and activity in prostate cancer cells (LNCaP).
Koochekpour S; Lee TJ; Wang R; Culig Z; Delorme N; Caffey S; Marrero L; Aguirre J
Prostate; 2007 Feb; 67(2):178-89. PubMed ID: 17044040
[TBL] [Abstract][Full Text] [Related]
14. Determinants of Gli2 co-activation of wildtype and naturally truncated androgen receptors.
Li N; Chen M; Truong S; Yan C; Buttyan R
Prostate; 2014 Oct; 74(14):1400-10. PubMed ID: 25132524
[TBL] [Abstract][Full Text] [Related]
15. The tumor suppressor ING1b is a novel corepressor for the androgen receptor and induces cellular senescence in prostate cancer cells.
Esmaeili M; Jennek S; Ludwig S; Klitzsch A; Kraft F; Melle C; Baniahmad A
J Mol Cell Biol; 2016 Jun; 8(3):207-20. PubMed ID: 26993046
[TBL] [Abstract][Full Text] [Related]
16. Prohibitin and the SWI/SNF ATPase subunit BRG1 are required for effective androgen antagonist-mediated transcriptional repression of androgen receptor-regulated genes.
Dai Y; Ngo D; Jacob J; Forman LW; Faller DV
Carcinogenesis; 2008 Sep; 29(9):1725-33. PubMed ID: 18487222
[TBL] [Abstract][Full Text] [Related]
17. A competitive inhibitor that reduces recruitment of androgen receptor to androgen-responsive genes.
Cherian MT; Wilson EM; Shapiro DJ
J Biol Chem; 2012 Jul; 287(28):23368-80. PubMed ID: 22589544
[TBL] [Abstract][Full Text] [Related]
18. The beta-catenin binding protein ICAT modulates androgen receptor activity.
Zhuo M; Zhu C; Sun J; Weis WI; Sun Z
Mol Endocrinol; 2011 Oct; 25(10):1677-88. PubMed ID: 21885566
[TBL] [Abstract][Full Text] [Related]
19. Investigation of androgen receptor-dependent alternative splicing has identified a unique subtype of lethal prostate cancer.
Seltzer S; Giannopoulos PN; Bismar TA; Trifiro M; Paliouras M
Asian J Androl; 2023; 25(3):296-308. PubMed ID: 36259569
[TBL] [Abstract][Full Text] [Related]
20. Crosstalk between the androgen receptor and beta-catenin in castrate-resistant prostate cancer.
Wang G; Wang J; Sadar MD
Cancer Res; 2008 Dec; 68(23):9918-27. PubMed ID: 19047173
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
